West Pharmaceutical Services | WST - Ordinary Share Capital


West Pharmaceutical Services reported $70.9M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Align Technology USD 71.62M 133K Mar/2026
Avanos Medical USD 46.67M 216.61K Mar/2026
Baxter International USD 516.45M 2.17M Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Charles River Laboratories USD 48.17M 1.05M Mar/2026
Cooper Companies USD 195.11M 14K Mar/2026
Dentsply International USD 200.3M 700K Mar/2026
Haemonetics USD 46.83M 82K Dec/2025
ICU Medical USD 24.69M 2K Dec/2025
Insulet USD 69.26M 1.08M Mar/2026
Integra LifeSciences USD 77.82M 69K Mar/2026
IQVIA Holdings USD 166.9M 2.7M Mar/2026
J&J USD 2.41B 1.74M Dec/2025
Medtronic USD 1.28B 1.38M Dec/2025
Merit Medical Systems USD 59.65M 231K Mar/2026
Neogen USD 217.67M 147K Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Quidel USD 67.9M 0 Dec/2025
Repligen USD 56.4M 74K Mar/2026
Solventum Corp USD 173.53M 40.79K Mar/2026
STAAR Surgical USD 49.78M 377K Mar/2026
Terumo JPY 1.48B 11K Mar/2026
Utah Medical Products USD 3.19M 3.15M Dec/2025
West Pharmaceutical Services USD 70.9M 1.1M Mar/2026